time, postoperative activity time, and postoperative hospital stay in the two groups were compared. Results: All operations were completed successfully in both groups. Compared with Open Surgery Group, the operation time [(177.2±36.9) vs. (229.6±28.1) min, t=−7.004, P=0.000], postoperative activity time [(2.7±0.7) vs. (4.1±1.0) d, t=−6.802, P=0.000] and hospital stay [(6.9±1.0) vs. (8.6±1.5) d, t=−5.448, P=0.000] of cystoscopy group were shorter. No recurrence or metastasis was observed from a follow-up of 6-120 months (median=32 months) in the two groups. Conclusions: Transurethral surgery is superior to traditional open surgery in trauma degree and postoperative recovery time. Transurethral Holmium laser resection of the distal ureter and bladder cuff is a minimally invasive and safety technique in the nephroureterectomy for the treatment of UTUC. Cite this abstract as: Ge Y. Holmium laser resection of the distal ureter and bladder cuff during radical nephroureterectomy for patients with pelvis or ureteral cancer.
Objective: To evaluate the clinical significance of lymphovascular invasion (LVI) on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection Methods: This retrospective study was performed with 155 patients with newly diagnosed pT1 urothelial carcinoma of bladder who were treated with transurethral resection of bladder tumor (TURBT) at our institution from January 2006 to January 2010. The presence or absence of LVI was examined according to our pathologists. Chi-square was performed to identify the correlations between LVI and other clinical and pathological features. Kaplan-Meier method was used to estimate the recurrence-free survival (RFS) and progression-free survival (PFS) curves and difference was determined by the log-rank test. Univariate and multivariate analyses were performed to determine the predictive factors through a Cox proportional hazards regression model. Results: LVI was detected in a total of 34 patients (21.9%). While LVI was associated with high grade tumors (P<0.001) and intravesical therapy (P=0.009). Correlations with age (P=0.227), gender (P=0.376), tumor size (P=0.969), tumor multiplicity (P=0.196), carcinoma in situ (CIS) (P=0.321) and smoking (P=0.438) were not statistically significant. There was a statistically significant tendency towards higher recurrence rate and shorter RFS time in LVI-positive patients. However, no statistically significant differences were observed in progression rate between the two groups. Moreover, multivariate Cox proportional hazards analysis revealed that LVI, tumor size and smoking were independent prognostic predictors of recurrence. The hazard ratios (95% confidence interval) were 2.042 (1.113-3.746, P=0.021), 1.817 (1.014-3.256, P=0.045) and 2.079 (1.172-3.687, P=0.012) respectively.
Conclusions:
The presence of LVI in TURBT specimens is significantly associated with higher recurrence rate and shorter RFS time in patients with newly diagnosed T1 urothelial carcinoma of the bladder. It is an independent prognostic predictor for disease recurrence. Thus, patients with LVI should be followed up closely. 
